Professor of Pathology
Pathology
Dr. Richard J. Zaino, MD
|
|
Give Review
Richard Zaino is an expert in the field of Pathology. He studied medicine at Duke University School of Medicine. Duke University School of Medicine is a one of the best medicals schools. Duke University School of Medicine is ranked 8 in research and 29 in primary care medicine Richard Zaino is a published doctor. He has 34 publications published. The most current publication "Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncolo..." He is registered with Medicare and accepts Medicare payments.
Publications
- Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncolo...
- Histologic effects of medroxyprogesterone acetate on endometrioid endometrial adenocarcinoma: a gynecologic oncology group study.
- Unusual Patterns of Endometrial Carcinoma Including MELF and its Relation to Epithelial Mesenchymal Transition.
- Temsirolimus with or without megestrol acetate and tamoxifen for endometrial cancer: A gynecologic oncology group study.
- Etiologic heterogeneity in endometrial cancer: evidence from a Gynecologic Oncology Group trial.
- Endometrial Dye Instillation: A Novel Approach to Histopathologic Evaluation of Morcellated Hysterectomy Specimens.
- Endocervical involvement in endometrial adenocarcinoma is not prognostically significant and the pathologic assessment of the pattern of involvement is not reproducible.
- Karyometry in atypical endometrial hyperplasia: A Gynecologic Oncology Group study.
- Advanced stage mucinous adenocarcinoma of the ovary is both rare and highly lethal: a Gynecologic Oncology Group study.
- Significant variation in the assessment of cervical involvement in endometrial carcinoma: an interobserver variation study.
- The fallopian tube-peritoneal junction: a potential site of carcinogenesis.
- Upstaging pathologic stage I ovarian carcinoma based on dense adhesions is not warranted: a clinicopathologic study of 84 patients originally classified as FIGO stage II.
- High levels of expression of human stromal cell-derived factor-1 are associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma.
- Adenocarcinoma arising in a rectovaginal fistula in Crohn disease.
- Preparing residents for practice. An opportunity to teach professionalism and communication skills as well as diagnostic criteria.
- Endometrial changes from short-term therapy with CDB-4124, a selective progesterone receptor modulator.
- FIGO staging of endometrial adenocarcinoma: a critical review and proposal.
- Endometrial development and function in experimentally induced luteal phase deficiency.
- Effects of continuous versus cyclical oral contraception: a randomized controlled trial.
- Relationship of estrogen and progesterone receptors to clinical outcome in metastatic endometrial carcinoma: a Gynecologic Oncology Group Study.
- The effects of metformin and rosiglitazone, alone and in combination, on the ovary and endometrium in polycystic ovary syndrome.
- Benign endometrial hyperplasia sequence and endometrial intraepithelial neoplasia.
- A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology grou...
- Reproducibility of the diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study.
- A critical analysis of the accuracy, reproducibility, and clinical utility of histologic endometrial dating in fertile women.
- Distinction of endocervical and endometrial adenocarcinomas: immunohistochemical p16 expression correlated with human papillomavirus (HPV) DNA detection.
- Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature.
- Lymph-vascular space invasion in endometrial adenocarcinoma: confusion, confessions, and conclusions.
- Symposium part I: adenocarcinoma in situ, glandular dysplasia, and early invasive adenocarcinoma of the uterine cervix.
- Comprehensive analysis of human leukocyte antigen class I alleles and cervical neoplasia in 3 epidemiologic studies.
- Hormone receptor immunohistochemistry and human papillomavirus in situ hybridization are useful for distinguishing endocervical and endometrial adenocarcinomas.
- Human leukocyte antigen class I alleles and cervical neoplasia: no heterozygote advantage.
- The fruits of our labors: distinguishing endometrial from endocervical adenocarcinoma.
Schools
Duke University
Duke University Med Center
Doctors Specialties
- Pathology
Accepted Insurances
- American Republic
- CoreSource
- Coventry Health America PPO
- Community Blue PPO
- Medicaid
- Medicare MCR
- Navigate HMO
- United Healthcare
Education
-
Duke University Hospital -
Duke University School of Medicine
Hospital
-
Penn State Milton S. Hershey Medical Center
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1194789842 |
| Last Name Of The Provider | ZAINO |
| First Name Of The Provider | RICHARD |
| View All |
Similar Doctors
|
|
Dr. Arthur B. Abt, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Catherine S. Abendroth, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William J. Castellani, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Loren E. Clarke, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Glenn S. Gerhard, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Haresh Mani, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Javad Towfighi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Meghan Riley, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Xuebin Yang, MD
This Doctor is OpenDoctor Recommended.
|